A polypill containing three recommended heart failure therapies improved heart function, reduced hospitalizations and was ...

A suburban Chicago father and his 1-year-old daughter were pepper-sprayed at close range as they headed grocery shopping over ...

Full results from the Phase 2 REGEN-007 study of rilparencel were recently presented as a late-breaking clinical trial at the American Society of ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Instead of simply pushing for a limited number of automatic qualifiers in the next version of the College Football Playoff, ...

Private brands aren’t riding a wave. They are the wave. And for Peggy Davies, president of the Private Label Manufacturers Association (PLMA), that momentum will be on full display at the 2025 PLMA ...

StandardAero (NYSE: SARO) announced results today for the three months ended September 30, 2025 ("Third Quarter 2025").